Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 9
July 2024
Volume 65, Issue 9
Open Access
ARVO Imaging in the Eye Conference Abstract  |   July 2024
Genetically Adjusted Optic Cup to Disc Ratio (CDR) Using a Two-Phase Training Deep Learning Model
Author Affiliations & Notes
  • Saber Kazeminasab Hashemabad
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Surya Pulukuri
    Harvard Medical School, Boston, Massachusetts, United States
  • Yan Zhao
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Kanza Aziz
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Sayuri Sekimitsu
    Tufts University School of Medicine, Boston, Massachusetts, United States
  • Mohammad Eslami
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Yan Luo
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Min Shi
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Yu Tian
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Hannah Rana
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Milen Raytchev
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Mengyu Wang
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Tobias Elze
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Janey Wiggs
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Nazlee Zebardast
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Saber Kazeminasab Hashemabad, None; Surya Pulukuri, None; Yan Zhao, None; Kanza Aziz, None; Sayuri Sekimitsu, None; Mohammad Eslami, None; Yan Luo, None; Min Shi, None; Yu Tian, None; Hannah Rana, None; Milen Raytchev, None; Mengyu Wang, Genentech Inc (F); Tobias Elze, Genentech Inc (F); Janey Wiggs, None; Nazlee Zebardast, Character Biosciences (Consultant) (F)
  • Footnotes
    Support  BrightFocus Foundation; NIH: R01 EY030575, P30 EY003790; NIH: K23EY032634; RPB (Research to Prevent Blindness) CDA (Career Development Award)
Investigative Ophthalmology & Visual Science July 2024, Vol.65, PB0027. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Saber Kazeminasab Hashemabad, Surya Pulukuri, Yan Zhao, Kanza Aziz, Sayuri Sekimitsu, Mohammad Eslami, Yan Luo, Min Shi, Yu Tian, Hannah Rana, Milen Raytchev, Mengyu Wang, Tobias Elze, Janey Wiggs, Nazlee Zebardast; Genetically Adjusted Optic Cup to Disc Ratio (CDR) Using a Two-Phase Training Deep Learning Model. Invest. Ophthalmol. Vis. Sci. 2024;65(9):PB0027.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The optic cup-to-disc ratio (CDR) is crucial in diagnosing glaucoma. While most studies to date use a CDR cut-off of 0.7 as indicative of glaucoma, clinically patients with glaucoma often have a CDR less than 0.7 and vice versa. The ability to differentiate pathologic from physiologic optic disc cupping is critical for improving glaucoma risk assessment and diagnostic accuracy. Here, we aim to adjust CDR for the patients based on their genetic characteristics.

Methods : We calculated a CDR polygenic risk score (PRS) for 6575 patients with ocular data in a Mass General Brigham (MGB) clinical biobank based on primary open-angle glaucoma (POAG) independent loci associated with CDR in a prior large genome-wide association study [1]. We trained a deep learning model with two-phase training: in the first phase the model is a classifier predicting patient status based on ICD codes (0, non-glaucoma eye or 1, glaucomatous eye) using the PRS and raw CDR values (Figure 1a1). In the second phase, the model's last layer is replaced with another layer to calculate the adjusted CDR. For the patients whose CDRs comply with the 0.7 criterion, their PRS and CDRs (i.e., raw CDRsL Figure 1a1) are input to the model and their CDRs are the outputs of the model (i.e., adjusted CDRs: Figure 1a2) in this phase.

Results : The cohort consisted of 53% females with an average age of 68.2 yrs (14.33 yrs/std). The majority were of European (86.55%) ancestry, while 6.18% were Hispanic, 5.46% African, and 1.81% Asian. There is a high-class imbalance in the dataset in which 85.61% of patients had no glaucoma ICD code, and 14.39% had at least one H40 or 365 ICD code. The model was tested with 399 samples (197 non-glaucoma, and 202 glaucomatous) which were manually reviewed by two ophthalmologists. Using the raw CDR values, 7.42% of non-glaucomatous eyes were misclassified as glaucomatous while 26.54% of glaucomatous eyes were misclassified as normal (Figure 1b). Adjusted CDR however achieved for comparison, the f1 score for the non-glaucoma eye class was 0.95 and 0.94 for the glaucoma eyes with a macro average is 0.94 (Figure 2a). The R2 score in the regression mode for the test set was 0.9989 (Figure 2b).

Conclusions : Using a CDR PRS and two-phase training deep learning, we were able to adjust CDR values for the patients to represent more accurate clinically verified disease.

This abstract was presented at the 2024 ARVO Imaging in the Eye Conference, held in Seattle, WA, May 4, 2024.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×